A Study of Vedolizumab and Biologic Agents in Participants With Inflammatory Bowel Disease (IBD)

CompletedOBSERVATIONAL

Enrollment

423

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

October 27, 2022

Study Completion Date

December 8, 2022

Conditions

Inflammatory Bowel Disease (IBD)Ulcerative ColitisCrohn's Disease

Trial Locations (4)

Chang Gung Memorial Hospital-Linkou, Taoyuan District

Taichung Veterans General Hospital, Taichung

National Taiwan University Hospital, Taipei

China Medical University Hospital, Taichung